Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
KB Home Reports Lower Revenue as Difficult Housing Market Persists
The home builder said revenue fell to $1.11 billion...
Jake Pratt’s Win in Nampa Gives the Veteran Cowboy New Momentum
After a dominant performance at the Snake River Stampede...
Goldman loses House seat after NY-10 Democratic primary defeat to Lander
Democratic Rep. Dan Goldman has lost his New York...
Wizards select AJ Dybantsa with the No. 1 pick
Friday, January 17th, 2025 at TD Garden, the Boston...